National Trends in Ambulatory Oral Anticoagulant Use Geoffrey D. Barnes, MD, MSc, Eleanor Lucas, BA, G. Caleb Alexander, MD, MS, Zachary D. Goldberger, MD, MS The American Journal of Medicine Volume 128, Issue 12, Pages 1300-1305.e2 (December 2015) DOI: 10.1016/j.amjmed.2015.05.044 Copyright © 2015 Elsevier Inc. Terms and Conditions
Figure 1 Quarterly use of oral anticoagulant during office visits. DOAC = direct oral anticoagulant. Source: IMS Health National Disease and Therapeutic Index, 2009-2014. The American Journal of Medicine 2015 128, 1300-1305.e2DOI: (10.1016/j.amjmed.2015.05.044) Copyright © 2015 Elsevier Inc. Terms and Conditions
Figure 2 Quarterly visits for atrial fibrillation by anticoagulant type. DOAC = direct oral anticoagulant. Source: IMS Health National Disease and Therapeutic Index, 2009-2014. The American Journal of Medicine 2015 128, 1300-1305.e2DOI: (10.1016/j.amjmed.2015.05.044) Copyright © 2015 Elsevier Inc. Terms and Conditions
Figure 3 Percentage of quarterly office visits for atrial fibrillation with anticoagulant use. Source: IMS Health National Disease and Therapeutic Index, 2009-2014. The American Journal of Medicine 2015 128, 1300-1305.e2DOI: (10.1016/j.amjmed.2015.05.044) Copyright © 2015 Elsevier Inc. Terms and Conditions